nefiracetam has been researched along with Acute Confusional Senile Dementia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moriguchi, S | 1 |
Marszalec, W; Moriguchi, S; Narahashi, T; Yeh, JZ; Zhao, X | 2 |
Kondoh, T; Matsuoka, T; Nishizaki, T; Nomura, T; Shiotani, T; Watabe, S; Yoshii, M | 1 |
Crespi, F | 1 |
3 review(s) available for nefiracetam and Acute Confusional Senile Dementia
Article | Year |
---|---|
Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II.
Topics: Alzheimer Disease; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dose-Response Relationship, Drug; Drug Delivery Systems; Hippocampus; Long-Term Potentiation; Neurons; Patch-Clamp Techniques; Pyrrolidinones; Rats | 2011 |
Mechanisms of action of cognitive enhancers on neuroreceptors.
Topics: Alzheimer Disease; Animals; Donepezil; Galantamine; Humans; Indans; Nicotinic Agonists; Nootropic Agents; Piperidines; Pyrrolidinones; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 2004 |
Nefiracetam. DM 9384, DZL 221, Translon.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Cognition Disorders; Humans; Pyrrolidinones | 2002 |
3 other study(ies) available for nefiracetam and Acute Confusional Senile Dementia
Article | Year |
---|---|
Unique mechanism of action of Alzheimer's drugs on brain nicotinic acetylcholine receptors and NMDA receptors.
Topics: Acetylcholine; Aconitine; Alzheimer Disease; Animals; Brain Chemistry; Bungarotoxins; Dihydro-beta-Erythroidine; Female; GTP-Binding Proteins; Hexamethonium; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Patch-Clamp Techniques; Pregnancy; Protein Kinases; Pyrrolidinones; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 2003 |
Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cognition Disorders; Electrophysiology; Glutamine; Hippocampus; Nootropic Agents; Oocytes; Protein Kinase C; Pyrrolidinones; Receptors, Nicotinic; Synaptic Transmission; Xenopus | 2000 |
Nefiracetam. Daiichi Seiyaku.
Topics: Administration, Oral; Alzheimer Disease; Animals; Central Nervous System Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia; Humans; Pyrrolidinones; Structure-Activity Relationship | 2002 |